Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Disease to Soft Tissue”

217 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 217 results

Testing effectiveness (Phase 2)UnknownNCT05138146
What this trial is testing

Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue Sarcoma

Who this might be right for
Sarcoma, Soft Tissue
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 70
Large-scale testing (Phase 3)Looking for participantsNCT05597917
What this trial is testing

TTF-NGR Randomized Study - STS

Who this might be right for
Soft Tissue Sarcoma
Universität Münster 126
Not applicableStudy completedNCT00335751
What this trial is testing

PET Scan Combined With CT Scan in Evaluating Treatment Response in Patients Undergoing Treatment for Bone Cancer or Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Jonsson Comprehensive Cancer Center 120
Testing effectiveness (Phase 2)Study completedNCT00385203
What this trial is testing

The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).

Who this might be right for
Gastrointestinal Stromal TumorsSoft Tissue Sarcomas
AstraZeneca 35
Testing effectiveness (Phase 2)UnknownNCT01541709
What this trial is testing

Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation: KENEDI

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 23
Testing effectiveness (Phase 2)Ended earlyNCT02054104
What this trial is testing

Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum

Who this might be right for
Thoracic SarcomasThorasic CancersCancers of Non-thoracic Origin With Metastases to the Lungs or Pleura+2 more
National Cancer Institute (NCI) 21
Large-scale testing (Phase 3)Ended earlyNCT00751036
What this trial is testing

Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 94
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)Study completedNCT01294202
What this trial is testing

Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST

Who this might be right for
Gastrointestinal Stromal Tumor (GIST)
Astex Pharmaceuticals, Inc. 26
Large-scale testing (Phase 3)Active Not RecruitingNCT02306161
What this trial is testing

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma

Who this might be right for
Metastatic Ewing SarcomaMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Bone Marrow+3 more
National Cancer Institute (NCI) 312
Not applicableLooking for participantsNCT07522762
What this trial is testing

Long-term Survivorship Challenges of Advanced/Metastatic GIST Patients Responding to Tyrosine Kinase Inhibitor Treatment: an Observational Study

Who this might be right for
Gastrointenstinal Stromal Tumor (GIST)
The Netherlands Cancer Institute 330
Testing effectiveness (Phase 2)Study completedNCT02511132
What this trial is testing

A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma

Who this might be right for
Ewing's Sarcoma
Gradalis, Inc. 22
Not applicableUnknownNCT04825470
What this trial is testing

Liver Transplantation for Unresectable GIST Liver Metastases

Who this might be right for
Liver DiseasesLiver CancerLiver Metastases+25 more
Hospital Universitario Virgen de la Arrixaca 50
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Not applicableWithdrawnNCT02465723
What this trial is testing

Detection of Acid Sphingomyelinase/Ceramide Pathway Activation in Radiotherapy Patients Using Intravoxel Incoherent Motion (IVIM) Diffusion-weighted Magnetic Resonance Imaging and Serum Biomarkers

Who this might be right for
Metastatic Disease to BoneMetastatic Disease to Soft Tissue
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07477457
What this trial is testing

Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma

Who this might be right for
OsteosarcomaMetastasis
Memorial Sloan Kettering Cancer Center 45
Testing effectiveness (Phase 2)Looking for participantsNCT05824975
What this trial is testing

Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more
GI Innovation, Inc. 358
Early research (Phase 1)Ended earlyNCT01313429
What this trial is testing

Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum

Who this might be right for
SarcomaMelanomaEpithelial Malignancies+1 more
National Cancer Institute (NCI) 19
Early research (Phase 1)Ended earlyNCT03604783
What this trial is testing

Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsSarcomaEwing Sarcoma+2 more
Sumitomo Pharma America, Inc. 74
Large-scale testing (Phase 3)Study completedNCT00134030
What this trial is testing

Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma

Who this might be right for
Localized OsteosarcomaMetastatic Osteosarcoma
Children's Oncology Group 1,334
Load More Results